Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 436

1.

Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.

Okutani Y, Kitanaka A, Tanaka T, Kamano H, Ohnishi H, Kubota Y, Ishida T, Takahara J.

Oncogene. 2001 Oct 4;20(45):6643-50.

PMID:
11641791
[PubMed - indexed for MEDLINE]
Free Article
2.

Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.

Chin H, Arai A, Wakao H, Kamiyama R, Miyasaka N, Miura O.

Blood. 1998 May 15;91(10):3734-45.

PMID:
9573010
[PubMed - indexed for MEDLINE]
Free Article
3.

A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.

Arcasoy MO, Harris KW, Forget BG.

Exp Hematol. 1999 Jan;27(1):63-74.

PMID:
9923445
[PubMed - indexed for MEDLINE]
4.

Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.

Chin H, Wakao H, Miyajima A, Kamiyama R, Miyasaka N, Miura O.

Blood. 1997 Jun 15;89(12):4327-36.

PMID:
9192755
[PubMed - indexed for MEDLINE]
Free Article
5.

Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases.

Paukku K, Valgeirsdóttir S, Saharinen P, Bergman M, Heldin CH, Silvennoinen O.

Biochem J. 2000 Feb 1;345 Pt 3:759-66.

PMID:
10642538
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5.

Okajima Y, Matsumura I, Nishiura T, Hashimoto K, Yoshida H, Ishikawa J, Wakao H, Yoshimura A, Kanakura Y, Tomiyama Y, Matsuzawa Y.

J Biol Chem. 1998 Sep 4;273(36):22877-83.

PMID:
9722506
[PubMed - indexed for MEDLINE]
Free Article
7.

Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells.

Sharlow ER, Pacifici R, Crouse J, Batac J, Todokoro K, Wojchowski DM.

Blood. 1997 Sep 15;90(6):2175-87.

PMID:
9310468
[PubMed - indexed for MEDLINE]
Free Article
8.

Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.

Tong W, Zhang J, Lodish HF.

Blood. 2005 Jun 15;105(12):4604-12. Epub 2005 Feb 10.

PMID:
15705783
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Physical and functional interactions between Stat5 and the tyrosine-phosphorylated receptors for erythropoietin and interleukin-3.

Chin H, Nakamura N, Kamiyama R, Miyasaka N, Ihle JN, Miura O.

Blood. 1996 Dec 15;88(12):4415-25.

PMID:
8977232
[PubMed - indexed for MEDLINE]
Free Article
10.

Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells.

Yamamura Y, Senda H, Kageyama Y, Matsuzaki T, Noda M, Ikawa Y.

Mol Cell Biol. 1998 Mar;18(3):1172-80.

PMID:
9488432
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Roles for an Epo receptor Tyr-343 Stat5 pathway in proliferative co-signaling with kit.

Li K, Miller C, Hegde S, Wojchowski D.

J Biol Chem. 2003 Oct 17;278(42):40702-9. Epub 2003 Aug 9.

PMID:
12909618
[PubMed - indexed for MEDLINE]
Free Article
12.

The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.

Akagi S, Ichikawa H, Okada T, Sarai A, Sugimoto T, Morimoto H, Kihara T, Yano A, Nakao K, Nagake Y, Wada J, Makino H.

J Am Soc Nephrol. 2004 Dec;15(12):3215-24.

PMID:
15579525
[PubMed - indexed for MEDLINE]
Free Article
13.
14.

Regulation of erythropoietin-induced STAT serine phosphorylation by distinct mitogen-activated protein kinases.

Haq R, Halupa A, Beattie BK, Mason JM, Zanke BW, Barber DL.

J Biol Chem. 2002 May 10;277(19):17359-66. Epub 2002 Mar 1.

PMID:
11875080
[PubMed - indexed for MEDLINE]
Free Article
15.
16.

Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways.

Wakao H, Harada N, Kitamura T, Mui AL, Miyajima A.

EMBO J. 1995 Jun 1;14(11):2527-35.

PMID:
7781605
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells.

Sakamoto H, Kitamura T, Yoshimura A.

J Biol Chem. 2000 Nov 17;275(46):35857-62.

PMID:
10960479
[PubMed - indexed for MEDLINE]
Free Article
18.

Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation.

Ilaria RL Jr, Hawley RG, Van Etten RA.

Blood. 1999 Jun 15;93(12):4154-66.

PMID:
10361113
[PubMed - indexed for MEDLINE]
Free Article
19.

Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity.

Gouilleux F, Pallard C, Dusanter-Fourt I, Wakao H, Haldosen LA, Norstedt G, Levy D, Groner B.

EMBO J. 1995 May 1;14(9):2005-13.

PMID:
7744007
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis.

Wakao H, Chida D, Damen JE, Krystal G, Miyajima A.

Biochem Biophys Res Commun. 1997 May 8;234(1):198-205.

PMID:
9168989
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk